These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Breath testing and antibiotics for possible bacterial overgrowth in irritable bowel syndrome. Ford AC Expert Rev Anti Infect Ther; 2010 Aug; 8(8):855-7. PubMed ID: 20695737 [No Abstract] [Full Text] [Related]
10. Irritable bowel syndrome and small intestinal bacterial overgrowth. Yamini D; Pimentel M J Clin Gastroenterol; 2010; 44(10):672-5. PubMed ID: 20838236 [TBL] [Abstract][Full Text] [Related]
11. Antibiotic may improve irritable bowel syndrome. Mayo Clin Health Lett; 2007 Mar; 25(3):4. PubMed ID: 17396340 [No Abstract] [Full Text] [Related]
12. The small intestinal bacterial overgrowth. Irritable bowel syndrome hypothesis: implications for treatment. Vanner S Gut; 2008 Sep; 57(9):1315-21. PubMed ID: 18250127 [No Abstract] [Full Text] [Related]
13. Small intestinal bacterial overgrowth produces symptoms in irritable bowel syndrome which are improved by rifaximin. A pilot study. Moraru IG; Portincasa P; Moraru AG; Diculescu M; Dumitraşcu DL Rom J Intern Med; 2013; 51(3-4):143-7. PubMed ID: 24620626 [TBL] [Abstract][Full Text] [Related]
14. Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin. Weinstock LB; Geng B; Brandes SB Can J Urol; 2011 Aug; 18(4):5826-30. PubMed ID: 21854715 [TBL] [Abstract][Full Text] [Related]
15. Microscopic colitis and small intestinal bacterial overgrowth--diagnosis behind the irritable bowel syndrome? Stoicescu A; Andrei M; Becheanu G; Stoicescu M; Nicolaie T; Diculescu M Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):766-72. PubMed ID: 23272525 [TBL] [Abstract][Full Text] [Related]
16. Breath Testing for Small Intestinal Bacterial Overgrowth: A Means to Enrich Rifaximin Responders in IBS Patients? Gupta A; Chey WD Am J Gastroenterol; 2016 Mar; 111(3):305-6. PubMed ID: 26925880 [No Abstract] [Full Text] [Related]
17. Gut flora and the irritable bowel syndrome. Kurtovic J; Riordan SM Am J Gastroenterol; 2004 May; 99(5):961-2. PubMed ID: 15128374 [No Abstract] [Full Text] [Related]
18. Rifaximin for the treatment of irritable bowel syndrome. Cremonini F; Lembo A Expert Opin Pharmacother; 2012 Feb; 13(3):433-40. PubMed ID: 22251066 [TBL] [Abstract][Full Text] [Related]
19. Use of rifaximin in gastrointestinal and liver diseases. Shayto RH; Abou Mrad R; Sharara AI World J Gastroenterol; 2016 Aug; 22(29):6638-51. PubMed ID: 27547007 [TBL] [Abstract][Full Text] [Related]
20. Antibiotic treatment of constipation-predominant irritable bowel syndrome: the puzzle is yet to be solved. Sachdeva S; Kondala R; Dahale AS; Puri AS Dig Dis Sci; 2014 Nov; 59(11):2836-7. PubMed ID: 25217237 [No Abstract] [Full Text] [Related] [Next] [New Search]